Subthalamic deep brain stimulation with a new device in Parkinson's disease: An open-label trial

Neuromodulation

Volumn 16, Issue 3, 2013, Pages 212-218

  Liu, Huan Guang ^a   Ma, Yu ^b   Zhang, Kai ^a   Ge, Ming ^a   Meng, Fan Gang ^b   Feng, Tao ^a   Wan, Xin Hua ^c   Guo, Yi ^c   Wang, Ren Zhi ^c   Yang, An Chao ^a   Hu, Wen Han ^b   Guo, Jin Zu ^c   Zhang, Jian Guo ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

deep brain stimulation; Parkinson's disease; PINS device; subthalamic nucleus; trial

Indexed keywords

LEVODOPA;

ADULT; ANXIETY; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONFUSION; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; DYSKINESIA; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; MALE; MEDICAL DEVICE; MORNING STIFFNESS; ON OFF PHENOMENON; OPEN STUDY; PARKINSON DISEASE; PROSPECTIVE STUDY; QUALITY CONTROL; SUBTHALAMIC NUCLEUS; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84878580910     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/ner.12050     Document Type: Article

References (54)

1. Lang AE, Widner H,. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002; 17: 94-101.
2. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
3. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128: 2240-2249.
4. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006; 21: 171-196.
5. Schüpbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5-year follow-up. J Neurol Neurosurg Psychiatry 2005; 76: 1640-1644.
6. Pahwa R, Wilkinson SB, Overman J, Lyons KE,. Bilateral subthalamic stimulation with Parkinson's disease: long-term follow-up. J Neurosurg 2003; 99: 71-77.
7. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE,. Long-term follow-up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson's disease. J Neurosurg 2003; 99: 489-495.
8. Anderson VC, Burchiel KJ, Hogarth P, Farve J, Hammerstad JP,. Pallidal vs. subthalamic nucleus deep brain stimulation in Parkinson's disease. Arch Neurol 2005; 62: 554-560.
9. Krause M, Fogel W, Heck A, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001; 70: 464-470.
10. Weaver F, Follet K, Hur K, Ippolito D, Stern M,. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg 2005; 103: 956-967.
11. Voges J, Koulousakis A, Sturm V,. Deep brain stimulation for Parkinson's disease. Acta Neurochir Suppl 2007; 97: 171-184.
12. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE,. Neurophysiological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123: 2091-2108.
13. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V,. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2001; 56: 548-551.
14. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077-2091.
15. Moro E, Lozano AM, Pollak P, et al. Longterm results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010; 25: 578-586.
16. Benabid AL, Pollak P, Louveau A, Henry S, de, Rougemont J,. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease. Appl Neurophysiol 1987; 50: 344-346.
17. Lyons MK,. Deep brain stimulation: current and future clinical applications. Mayo Clin Proc 2011; 86: 662-672.
18. Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol 2012; 11: 140-149.
19. Hu WH, Zhang K, Meng FG, Ma Y, Zhang JG,. Deep brain stimulation in China: present and future. Neuromodulation 2012; 15: 251-259.
20. Hauser RA, Deckers F, Lehert P,. Parkinson's disease home diary: further validation and implications for clinical trials. Mov Disord 2004; 19: 1409-1413.
21. Hauser RA, Friedlander J, Zesiewicz TA, et al. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia. Clin Neuropharmacol 2000; 23: 75-81.
22. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ,. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992; 42: 1142-1146.
23. Fahn S, Elton R, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In:, Fahn S, Marsden CD, Calne DB, et al., eds. Recent developments in Parkinson's disease. Vol. 2. Florham Park: Macmillan Health Care Information, 1987; 153-163. 293-304.
24. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ,. The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol 2010; 67: 64-70.
25. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
26. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21: 290-304.
27. Goodman RR, Kim B, McClelland S 3rd, et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 12-17.
28. Fraix V, Pollak P, Van Blercom N, et al. Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology 2000; 55: 1921-1923.
29. Herzog J, Volkmann J, Krack P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord 2003; 18: 1332-1337.
30. Østergaard K, Aa Sunde N,. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2006; 21: 624-631.
31. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ,. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord 2008; 14: 114-119.
32. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339: 1105-1111.
33. Lagrange E, Krack P, Moro E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 2002; 59: 1976-1978.
34. Lezcano E, Gõmez-Esteban JC, Zarranz JJ, et al. Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus. Eur J Neurol 2004; 11: 451-454.
35. Lyons KE, Pahwa R,. Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J Neurosurg 2005; 103: 252-255.
36. Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol 2005; 252: 583-588.
37. Martínez-Martín P, Valldeoriola F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002; 17: 372-377.
38. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010; 9: 581-591.
39. Zahodne LB, Okun MS, Foote KD, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol 2009; 256: 1321-1329.
40. D'Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR,. Effects of bilateral subthalamic nucleus stimulation and medication on Parkinsonian speech impairment. J Voice 2008; 22: 365-372.
41. Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J,. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2010; 81: 315-319.
42. Okun MS, Fernandez HH, Pedraza O, et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology 2004; 63: 161-163.
43. Follett KA,. Comparison of pallidal and subthalamic deep brain stimulation for the treatment of levodopa-induced dyskinesias. Neurosurg Focus 2004; 17: E3.
44. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586-595.
45. Kenney C, Simpson R, Hunter C, et al. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007; 106: 621-625.
46. Voges J, Waerzeggers Y, Maarouf M, et al. Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery-experiences from a single centre. J Neurol Neurosurg Psychiatry 2006; 77: 868-872.
47. Limousin P, Martinez-Torres I,. Deep brain stimulation for Parkinson's disease. Neurotherapeutics 2008; 5: 309-319.
48. Fraix V, Houeto JL, Lagrange C, et al. SPARK Study Group. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 443-449.
49. Valldeoriola F, Morsi O, Tolosa E, Rumià J, Martí MJ, Martínez-Martín P,. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord 2007; 22: 2183-2191.
50. Anheim M, Fraix V, Chabardes S, Krack P, Benabid AL, Pollak P,. Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease. Mov Disord 2007; 22: 2436-2439.
51. Benabid AL, Chabardes S, Mitrofanis J, Pollak P,. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 8: 67-81.
52. Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, de, Ferranti D,. Reform of how health care is paid for in China: challenges and opportunities. Lancet 2008; 372: 1846-1853.
53. Liu Y, Rao K, Wu J, Gakidou E,. China's health system performance. Lancet 2008; 372: 1914-1923.
54. Zhang ZX, Roman GC, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 2005; 365: 595-597.